Genetic clues to target pancreatic cancer faster

NCT ID NCT06574620

Summary

This study aims to see if quickly analyzing the genetic makeup of a pancreatic tumor can help doctors choose the most effective treatment. It will enroll 200 adults with pancreatic cancer that has not spread to distant organs. Participants will receive standard chemotherapy and provide tissue and blood samples for genetic testing to see if the results can predict how their cancer will respond to treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BC Cancer

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.